FDD-11311-38352
5 vaccinations
7 coded responses
19 check-ins
7 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 495 / MI
- Registered
- 2021-01-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Dose 1 — Pfizer-BioNTech
-
2021-01-29
Dose 2 — Pfizer-BioNTech
-
2021-01-31
Registered in v-safe
- 2021-02-01
- 2021-02-02
- 2021-02-05
-
2021-03-06
Survey response — day 35, dose 2MedDRA: Vitreous detachment — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Vitreous detachment left eye.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-30
-
2021-10-01
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-01
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Musculoskeletal discomfort, Pain in extremity — Feeling: Good · Site: Pain · HeadacheFree text: Sore neck (no pain chin to chest), some malaise. All sx (c arm pain by 5 pm)MedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-04
- 2021-10-07
- 2021-10-08
- 2021-10-25
-
2021-10-31
Survey response — day 28, dose 3MedDRA: Abdominal pain — Feeling: FairFree text: Increased abdominal pain.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-07
-
2021-12-31
Survey response — 3 months, dose 3MedDRA: Exercise tolerance decreased, Office visit, Oxygen saturation decreased, Presyncope — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Near syncope episode, decreased exercise tolerance, decreased resting SpO2. Needed ECG, stress echo, 7 day heart monitor and D-dimer · Healthcare visit (other): PCP office visitMedDRA releases: 2024-11 · check-in free text available
-
2021-12-31
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-01-04
-
2022-02-18
Call successfulParticipant prefers to complete VAERS report online
-
2022-04-01
Survey response — 6 months, dose 3MedDRA: Lymphadenopathy, Pelvic discomfort, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Need work up for pelvic fullness and enlarged lymph nodes. · Healthcare visit (other): US testingMedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-04
-
2022-05-11
Dose 4 — Moderna
-
2022-06-10
Survey response — day 28, dose 4MedDRA: Chest discomfort, Palpitations — Feeling: FairFree text: Increased heart palpations and chest tightness.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-17
Dose 5 — Pfizer-BioNTech
- 2022-09-23
-
2022-10-24
Survey response — day 35, dose 5MedDRA: Tinnitus — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Pulsatilla tinnitusMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Report sent to call center — day 35, dose 5Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-25
- 2022-10-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | Flu |
| 4 | 2022-05-11 | Moderna | No |
| 5 | 2022-09-17 | Pfizer-BioNTech | No |
Call center
4 call center cases
2 successful · 2 unsuccessful
Free text
Release 5 — day 35, dose 2
Symptoms: Vitreous detachment left eye.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Sore neck (no pain chin to chest), some malaise. All sx (c arm pain by 5 pm)
Release 10 — day 28, dose 3
Symptoms: Increased abdominal pain.
Release 10 — 3 months, dose 3
Symptoms: Near syncope episode, decreased exercise tolerance, decreased resting SpO2. Needed ECG, stress echo, 7 day heart monitor and D-dimer
Healthcare visit (other): PCP office visit
Release 11 — 6 months, dose 3
Symptoms: Need work up for pelvic fullness and enlarged lymph nodes.
Healthcare visit (other): US testing
Release 12 — day 28, dose 4
Symptoms: Increased heart palpations and chest tightness.
Release 12 — day 35, dose 5
Symptoms: Pulsatilla tinnitus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abdominal pain | · | · | ✓ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Exercise tolerance decreased | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Oxygen saturation decreased | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Pelvic discomfort | · | · | ✓ |
| SD | Presyncope | · | · | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SD | Vitreous detachment | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal discomfort | · | · | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release